CTOs on the Move

Capnia, Inc

www.capnia.com

 
Capnia, Inc., a privately held company headquartered in Redwood City, California, develops diagnostics based on its proprietary Sensalyze™ technology for precision metering of gas flow.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.capnia.com
  • 2445 Faber Pl Ste 250
    Palo Alto, CA USA 94303
  • Phone: 650.213.8444

Executives

Name Title Contact Details

Similar Companies

Suvida Healthcare

Suvida Healthcare is a healthcare center that is specially designed to address the unique needs of Hispanic seniors and their families.

MedMinder Systems

MedMinder Systems Inc. provides services that simplify medication management and improve medication adherence. We offer an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages & phone calls.

Empath Health

Empath Health is uniquely devoted to pioneering all-embracing care that provides for the full life. We`re here for all stages of care, for all dimensions of well-being and for all aspects dear to one`s life. We consider it a privilege and a calling to give more of ourselves in order to offer a truly exceptional experience, unlike any other.

Stallion Technologies Inc

Stallion Technologies Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.